ScreenerHero

OSL OncoSil Medical Limited

ASX · AU · Healthcare · Medical Devices & Supplies · oncosil.com
—Mkt Cap: —P/E: —

OncoSil Medical Limited, a medical device company, develops and commercializes localised radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company offers OncoSil, a single-use brachythe…

Industry Peers

Medical Devices & Supplies
Screen all
SI
Shoulder Innovations, Inc.
$382.44MUSDP/E 23.0
TEVO
Tevano Systems Holdings Inc.
$422.8KUSD
MMEDV
MiniMed Group, Inc. Common Stock When Issued
—

Key Statistics

Company
Market Cap—
Enterprise Value10.90M USD
Revenue (TTM)3.52M USD
Gross Profit-464.64K USD
Net Income (TTM)-7.51M USD
Revenue/Share0.23 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryMedical Devices & Supplies
ISINAU000000OSL3
Valuation
P/E (Trailing)—
P/E (Forward)-0.04
PEG—
EV/EBITDA-1.43
EV/Revenue3.10
P/S5.19
P/B4.44
EPS (TTM)-0.48
EPS (Forward)-18.40
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin-39.90%
Oper. Margin-336.60%
EBITDA Margin-216.20%
Profit Margin-644.53%
ROE-217.36%
ROA-105.32%
Growth
Revenue Growth248.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.24M USD
CapEx (TTM)1.01K USD
FCF Margin-123.74%
FCF Yield—
Net Debt-4.47M USD
Net Debt/EBITDA0.59
Balance Sheet
Debt/Equity0.00
Current Ratio1.77
Quick Ratio1.68
Book Value/Sh0.16 AUD
Cash/Share0.21 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:400
Split DateJun 3, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.36.70M
Float24.43M
Insiders8.73%
Institutions43.73%
Technical
SMA 500.9949 AUD
SMA 2000.7804 AUD
Beta1.31
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)63.01K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—